Global Duloxetine Market, By Strength (20mg, 30mg, 40mg, 60mg), Drug Class (Antidepressants, Fibromyalgia Agents, Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)), Application (Neuropathic Pain, Major Depressive Disorder, Fibromyalgia, Generalized Anxiety Disorder (GAD), Chronic Musculoskeletal Pain, Others), Type (Generic, Brand), Dosage Form (Oral Delayed Release Capsule, Others), Route of Administration (Oral, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Duloxetine Market
Duloxetine market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.60% in the above mentioned forecast period.
Duloxetine is a medication that is used to treat serious depressive disorders. It is a type of antidepressant known as a selective serotonin and norepinephrine reuptake inhibitor (SNRI). It is used to treat anxiety, depression and pain. Duloxetine primarily impacts neurotransmitters, which are chemicals produced and released by nerves in the brain to communicate with one another. Neurotransmitters either pass between nerves or attach to receptors on the surface of neighbouring nerves, or they attach to receptors on the surface of the nerves that create them, where they are taken up and released again.
The rise in the rate of anxiety cases and rising healthcare expenditure are the major factors influencing the market growth rate. Furthermore, growing prevalence of depression, rising demand for newly developed small molecule drugs and strong drug pipeline are the factors that will expand the duloxetine market. Other factors including rise in the number of geriatric population and growing preference as well as awareness about generic drugs will positively impact the market growth rate.
Moreover, the rise in the research and development activities and emerging new markets will provide beneficial opportunities for the duloxetine market in the forecast period of 2021-2028.
However, changing economic conditions in different regions and side effects associated with duloxetine are the factors that will hinder the market growth and will further challenge the duloxetine market in the forecast period mentioned above.
This duloxetine market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the duloxetine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Duloxetine Market Scope and Market Size
The duloxetine market is segmented on the basis of strength, drug class, application, type, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of strength, the duloxetine market is segmented into20mg, 30mg, 40mg, and 60mg.
- On the basis of drug class, the duloxetine market is segmented into antidepressants, fibromyalgia agents, and selective serotonin and norepinephrine reuptake inhibitors (SNRIs).
- On the basis of application, the duloxetine market is segmented into neuropathic pain, major depressive disorder, fibromyalgia, generalized anxiety disorder (GAD), chronic musculoskeletal pain and others.
- On the basis of type, the duloxetine market is segmented into generic, and brand.
- On the basis of dosage form, the duloxetine market is segmented into oral delayed release capsule and others.
- On the basis of route of administration, the duloxetine market is segmented into oral and others.
- On the basis of end-users, the duloxetine market is segmented into clinic, hospital and others.
- The duloxetine market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Duloxetine Market Country Level Analysis
Duloxetine market is analyzed and market size information is provided by the country, strength, drug class, application, type, dosage form, route of administration, end-users and distribution channel as referenced above.
The countries covered in the duloxetine market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the duloxetine market due to the rising awareness about diseases, presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising awareness about mentasl disorders in this region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Duloxetine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Duloxetine Market Share Analysis
Duloxetine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to duloxetine market research.
Some of the major players operating in the duloxetine market are Mylan N.V., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Lupin, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Apotex Inc., Hetero, Zydus Cadila, SHIONOGI & Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd., Shodhana Laboratories Limited, RL Fine Chem Pvt. Ltd., KINSY, Metrochem API Pvt Ltd., Uquifa, Transo-Pharm Handels-GmbH, Novartis AG, AJANTA PHARMA, and Torrent Pharmaceuticals Ltd., among others.
SKU-
